Werkgroep Cardiologische centra Nederland

SELECT (Follow-up)

Evaluation of cardiovascular outcomes with semaglutide in patients with overweight or obesity and prior MI/stroke
Medicine
semaglutide
Population
ASCVD
Phase
III
Starting year
2018
More information
Clinicaltrials.gov

Director of Study

dr. F.M.A.C. Martens (Cardioloog)
Deventer, Deventer Ziekenhuis